Controlling HCV in Switzerland: running against the clock

The use and reimbursement of direct-asting antivirals for all HCV-infected patients (regardless of the stage of disease) has been permitted in Switzerland since November 2017. Although at the outset treatment rates were high, they recently dropped dramatically.

Setting as informed consent in psychotherapy

This paper argues that informed consent has been a crucial element in psychotherapy since its beginnings, but under another name: the setting.

Chronic heart failure: advances in pharmacological treatment and future perspectives

Recent years have shown that progress in heart failure therapy may not necessarily come from obvious sources. In the long run, it will pay to stay curious and keep an open mind for the exploration of potential new avenues in the future.   

Teamwork and clinician burnout in Swiss intensive care: the predictive role of workload, and demographic and unit characteristics

Levels of teamwork and clinician burnout in healthcare differ depending on demographic and unit characteristics, whose impact varies between clinical settings.

Uncertain progress in Swiss perioperative mortality 1998–2014 for 22 operation groups

The Swiss Federal Office of Public Health publishes national in-hospital mortality rates for several indicator conditions and procedures. Perioperative mortality rate (POMR) is a quality indicator used to monitor healthcare system performance.

Home visits made by general practitioners in the canton of Vaud between 2006 and 2015

The vast majority of physicians in the Canton of Vaud continue to visit patients at home, but the overall number of home visits is declining. In the context of an ageing population, the role of physicians within new models of care should address the demand for home visits.

A prospective observational study of the main features of nocturnal leg cramps in primary care

Nocturnal leg cramps are common among older patients in primary care, but only some patients suffer from a relatively high number of cramps and/or cramps seriously affecting their quality of life. Future research should focus on the development of new approaches with real therapeutic benefits to treat these patients.

Cost-effectiveness analysis of strategies to manage the disease burden of hepatitis C virus in Switzerland

Increasing the number of patients treated and treating all fibrosis stages is cost-effective compared against the historical base case and could achieve a break-even by 2031 at a price of 27,900 CHF.

Informed consent for psychotherapy includes much more than the setting